These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8623336)

  • 1. In vivo evaluation of human membrane cofactor protein in transgenic mice.
    IJzermans JN; Schraa EO; Bonthuis F; Yannnoutsos N; Marquet RL
    Transplant Proc; 1996 Apr; 28(2):671-2. PubMed ID: 8623336
    [No Abstract]   [Full Text] [Related]  

  • 2. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell- and tissue-specific expression of a human CD59 minigene in transgenic mice.
    Diamond LE; Oldham ER; Platt JL; Waldmann H; Tone M; Walsh LA; Logan JS
    Transplant Proc; 1994 Jun; 26(3):1239. PubMed ID: 7518115
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells.
    Kooyman D; Byrne G; McClellan S; Nielsen D; Kagan D; Coffman T; Masahide T; Waldmann H; Platt J; Logan J
    Transplant Proc; 1994 Jun; 26(3):1241. PubMed ID: 7518117
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
    Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
    [No Abstract]   [Full Text] [Related]  

  • 6. Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo model.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Melli C; Bruzzone P; Alfani D
    Transplant Proc; 1996 Apr; 28(2):589. PubMed ID: 8623287
    [No Abstract]   [Full Text] [Related]  

  • 7. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 10. Ex vivo perfusion of mouse hearts expressing the human complement regulatory protein CD59.
    Harland RC; Logan JS; Kooyman D; Byrne GW; Platt JL
    Transplant Proc; 1994 Jun; 26(3):1245. PubMed ID: 7518120
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of pigs transgenic for human decay accelerating factor.
    Langford GA; Yannoutsos N; Cozzi E; Lancaster R; Elsome K; Chen P; Richards A; White DJ
    Transplant Proc; 1994 Jun; 26(3):1400-1. PubMed ID: 7518134
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
    Iborra A; Mayorga M; Llobet N; Martínez P
    Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
    Cary N; Moody J; Yannoutsos N; Wallwork J; White D
    Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
    [No Abstract]   [Full Text] [Related]  

  • 14. An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.
    Mora M; Lazzer M; Marsicano G; Mulder LC; Carraresi L; Pieri A; Benanchi A; Grifoni D; Nuti S; Bruzzone P; Comporti M; Cortesini R; Rossini M
    Transgenic Res; 2000 Jun; 9(3):205-13. PubMed ID: 11032369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenotransplantation of pig organs transgenic for human DAF: an update.
    Schmoeckel M; Bhatti FN; Zaidi A; Cozzi E; Pino-Chavez G; Dunning JJ; Wallwork J; White DJ
    Transplant Proc; 1997 Nov; 29(7):3157-8. PubMed ID: 9365707
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative analysis of human DAF expression in the tissues of transgenic pigs and man.
    Cozzi E; Langford GA; Wright L; Tucker A; Yannoutsos N; Richards A; Rosengard A; Elsome K; Lancaster R; White DJ
    Transplant Proc; 1995 Feb; 27(1):319-20. PubMed ID: 7533397
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of pigs transgenic for human regulators of complement activation using YAC technology.
    Langford GA; Cozzi E; Yannoutsos N; Lancaster R; Elsome K; Chen P; White DJ
    Transplant Proc; 1996 Apr; 28(2):862-3. PubMed ID: 8623438
    [No Abstract]   [Full Text] [Related]  

  • 18. Human nasal epithelium adsorbs complement C3-related fragments and expresses cell membrane complement regulatory proteins.
    Varsano S; Frolkis I; Shapiro H; Ophir D
    Laryngoscope; 1996 May; 106(5 Pt 1):599-604. PubMed ID: 8628088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
    van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
    Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
    [No Abstract]   [Full Text] [Related]  

  • 20. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
    Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
    Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.